Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessestablishment of organelle localization

RAB11B MYH9 LSG1 PCLO SYBU CHAMP1 SPAG5 ABRAXAS2 KIF3B MAP1S BRCA2 DOCK7 UNC13C NLRP4 ARHGAP21

4.33e-0654613915GO:0051656
GeneOntologyBiologicalProcessnon-motile cilium assembly

ATMIN RPGRIP1L CEP350 CEP89 CEP250 RP1

1.45e-05781396GO:1905515
GeneOntologyBiologicalProcessmitotic DNA replication maintenance of fidelity

RAD51 BRCA2

4.51e-0521392GO:1990505
GeneOntologyBiologicalProcessmitotic recombination-dependent replication fork processing

RAD51 BRCA2

4.51e-0521392GO:1990426
GeneOntologyBiologicalProcesscell cycle DNA replication maintenance of fidelity

RAD51 BRCA2

4.51e-0521392GO:1902298
GeneOntologyBiologicalProcessorganelle localization

RAB11B MYH9 LSG1 PCLO SYBU CHAMP1 SPAG5 ABRAXAS2 KIF3B MAP1S BRCA2 DOCK7 UNC13C NLRP4 ARHGAP21

8.17e-0570313915GO:0051640
MousePhenodecreased respiration

MIA3 NR3C1 ITGB4 FBN1 LRP4 PHF14 GNB1 GCN1 EPAS1

5.21e-061701059MP:0014274
MousePhenorespiratory failure

MIA3 NR3C1 ITGB4 LRP4 PHF14 GNB1 GCN1 EPAS1

3.36e-051651058MP:0001953
MousePhenodecreased fetal size

CUL4B ATMIN MIA3 CHD2 SAFB BRCA2 VCAN SUCO GCN1

5.58e-052291059MP:0004200
MousePhenoabnormal fetal size

CUL4B ATMIN MIA3 CHD2 SAFB BRCA2 VCAN SUCO GCN1

7.27e-052371059MP:0004198
PathwayWP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR

RAD51 MDM2 BRCA2 HERC2 POLN CDC25C

1.62e-0581946M39490
PathwayWP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM

RAD51 MDM2 RIF1 BRCA2 CDC25C

3.17e-0555945M39598
PathwayPID_ATR_PATHWAY

RAD51 MDM2 BRCA2 CDC25C

1.28e-0439944M46
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RAD51 MYH9 ZGRF1 DVL3 CHAMP1 SPAG5 KIAA1671 ZNF462 BRCA2 RABEP1 N4BP2 XRN1 DOCK7 CRYBG3 GCN1 ARHGAP21 ZMYM4

2.66e-124181461734709266
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

SETX LSG1 KIAA0232 SEC24A DAPK2 KDM3B GIGYF1 SPECC1 CEP350 KIAA1671 CEP89 ANLN RABEP1 N4BP2 XRN1 DOCK7 HELZ AKAP11 CRYBG3 CDC25C ARHGAP21

9.67e-118611462136931259
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

MIA3 SEC24A DVL3 GIGYF1 GGA3 KIAA1671 XRN1 HELZ CRYBG3 GCN1 ATP2B3 ARHGAP21

1.37e-092631461234702444
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ATMIN IQSEC3 FRMPD4 KIAA0513 KIAA0232 SPEG DNAJC6 TENM2 USP19 GGA3 KIF3B DOCK7 ANKRD12 ARHGAP21

2.15e-094071461412693553
Pubmed

A human MAP kinase interactome.

MYH9 SETX KIAA0232 MYNN FAM13B ITGB4 CEP350 RIF1 TSC22D1 N4BP2 CEP250 HELZ HERC2 GCN1 EPAS1

2.43e-094861461520936779
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

CUL4B MIA3 RPGRIP1L KIAA0232 SEC24A CFI GFPT1 SPAG5 GGA3 CEP350 KIAA1671 PPP2R3A BRCA2 N4BP2 CEP250 XRN1 HERC2 GNB1 ARHGAP21

3.59e-098531461928718761
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

RAB11B PAG1 MYH9 DVL3 SPECC1 GGA3 EFR3A KIAA1671 ANLN XRN1 CTNNA2 KDF1 GCN1 DHX29 ARHGAP21

1.81e-085651461525468996
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MIA3 LSG1 SPAG5 CEP350 KIAA1671 RABEP1 DOCK7 AKAP11 CRYBG3 ARHGAP21

2.15e-082091461036779422
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

IQSEC3 MYH9 MIA3 FRMPD4 KIAA0513 PCLO DVL3 TENM2 SAFB MAP1S RABEP1 XRN1 FAM169A DOCK7 HELZ CTNNA2 LNPK CRYBG3 GCN1 DHX29

6.99e-0811391462036417873
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

MYH9 LSG1 KDM3B NR3C1 CHAMP1 GFPT1 SPAG5 GGA3 KIAA1671 RIF1 SAFB RABEP1 XRN1 FAM169A HELZ GCN1 DHX29 ARHGAP21

8.51e-089341461833916271
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

MIA3 RPGRIP1L LSG1 ICE2 SPECC1 GGA3 CEP350 CEP89 RABEP1 AKAP11

1.20e-072511461029778605
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

RAB11B MYH9 SETX RPGRIP1L LSG1 SEC24A KDM3B USP19 CEP350 KIAA1671 RIF1 PPP2R3A XRN1 DOCK7 GCN1 ARHGAP21

1.94e-077771461635844135
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

IQSEC3 MYH9 MIA3 LSG1 DNAJC6 TENM2 ZNF462 KIF3B RABEP1 N4BP2 DOCK7 CTNNA2 HERC2 GNB1 TNR KCNT1 ARHGAP21

6.74e-079631461728671696
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

GGNBP2 MIA3 SETX LSG1 KDM3B GIGYF1 NR3C1 SPAG5 XRN1 DOCK7 HELZ CRYBG3 ARHGAP21 RIC1

6.92e-076501461438777146
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RAB11B MYH9 GGNBP2 PCDHGA9 LSG1 PCLO CHD2 MYNN ACTN2 ABCB1 SAFB MLIP N4BP2 DGKK XRN1 FAM169A PHF14 EEA1 GNB1 ATP2B3 ARHGAP21

7.00e-0714421462135575683
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

MYH9 PCLO DVL3 CHAMP1 GFPT1 MAP1S VCAN XRN1 CTNNA2 GCN1 DHX29 ARHGAP21

1.42e-064981461236634849
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

MIA3 RPGRIP1L SEC24A PTPRU EFR3A CEP350 KIAA1671 ABRAXAS2 CNNM4 RIF1 PPP2R3A CEP89 HELZ CRYBG3 HERC2 CDC25C GCN1

2.15e-0610491461727880917
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

IQSEC3 MYH9 DOCK8 PCLO MBP ACTN2 DNAJC6 SPECC1 SAFB MLIP MAP1S VCAN XRN1 DOCK7 CTNNA2 GNB1 TNR DHX29 ATP2B3 ARHGAP21

2.47e-0614311462037142655
Pubmed

Elongator and codon bias regulate protein levels in mammalian peripheral neurons.

SETX BRCA2 VCAN

2.51e-067146329497044
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

MIA3 DOCK8 GIGYF1 KIAA1671 ABRAXAS2 MAP1S CEP89 RABEP1 DOCK7 HELZ CDC25C

3.17e-064461461124255178
Pubmed

LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.

PCLO GIGYF1 MDM2 DCST1 ADGRG4 CEP350 N4BP2 CEP250 ZNF804B DOCK7 HELZ CTNNA2 HERC2

3.28e-066391461323443559
Pubmed

Brca2 is required for embryonic cellular proliferation in the mouse.

RAD51 MDM2 BRCA2

5.98e-06914639171369
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

SETX RPGRIP1L ZGRF1 NR3C1 MDM2 KIAA1671 BRCA2 RABEP1 N4BP2 HELZ CRYBG3 ZMYM4

7.70e-065881461238580884
Pubmed

Functional proteomics mapping of a human signaling pathway.

DMTF1 DOCK8 PPP1R3B DVL3 KDM3B GGA3 ABRAXAS2 KIF3B CEP250 ZCCHC7 HERC2 EPAS1

8.10e-065911461215231748
Pubmed

Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.

MYH9 SPECC1 DOCK7 CTNNA2 ARHGAP21

9.53e-0667146529254152
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

MYH9 SETX GIGYF1 CHAMP1 ITGB4 GFPT1 RIF1 SAFB ANLN CDC25C DHX29

9.84e-065031461116964243
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

SETX KDM3B CHD2 CHAMP1 ZNF462 RIF1 ANLN ATAD2B FAM169A PHF14 HERC2 ZMYM4

1.07e-056081461236089195
Pubmed

Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.

RAD51 BRCA2

1.75e-052146234978208
Pubmed

Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.

RAD51 BRCA2

1.75e-05214629523196
Pubmed

Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity.

RAD51 BRCA2

1.75e-052146221789034
Pubmed

Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms.

RAD51 BRCA2

1.75e-052146221670257
Pubmed

Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control.

RAD51 BRCA2

1.75e-052146210551859
Pubmed

Nascent DNA synthesis during homologous recombination is synergistically promoted by the rad51 recombinase and DNA homology.

RAD51 BRCA2

1.75e-052146224583581
Pubmed

BRCA2-dependent and independent formation of RAD51 nuclear foci.

RAD51 BRCA2

1.75e-052146212606939
Pubmed

Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus.

RAD51 BRCA2

1.75e-052146228067217
Pubmed

BRCA2 BRC motifs bind RAD51-DNA filaments.

RAD51 BRCA2

1.75e-052146215937124
Pubmed

Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.

RAD51 BRCA2

1.75e-052146218632222
Pubmed

Structure of human BRCA2-RAD51 by molecular docking study.

RAD51 BRCA2

1.75e-052146217549502
Pubmed

DNA Strand Exchange to Monitor Human RAD51-Mediated Strand Invasion and Pairing.

RAD51 BRCA2

1.75e-052146232840775
Pubmed

Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations.

RAD51 BRCA2

1.75e-052146231575654
Pubmed

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

RAD51 BRCA2

1.75e-05214629560268
Pubmed

Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein.

RAD51 BRCA2

1.75e-052146218429819
Pubmed

Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond.

RAD51 BRCA2

1.75e-052146237651978
Pubmed

Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks.

FBN1 VCAN

1.75e-052146211726670
Pubmed

Application of the wheat-germ cell-free translation system to produce high temperature requirement A3 (HtrA3) proteases.

MYH9 HTRA3

1.75e-052146222229724
Pubmed

Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide.

RAD51 BRCA2

1.75e-052146216513631
Pubmed

Protein kinase D promotes activity-dependent AMPA receptor endocytosis in hippocampal neurons.

RABEP1 EEA1

1.75e-052146234564930
Pubmed

Polymorphisms of the BRCA2 and RAD51 genes in breast cancer.

RAD51 BRCA2

1.75e-052146216261408
Pubmed

Homotypic versican G1 domain interactions enhance hyaluronan incorporation into fibrillin microfibrils.

FBN1 VCAN

1.75e-052146223963449
Pubmed

Valine 1532 of human BRC repeat 4 plays an important role in the interaction between BRCA2 and RAD51.

RAD51 BRCA2

1.75e-052146221601571
Pubmed

Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.

RAD51 BRCA2

1.75e-052146217515903
Pubmed

Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2.

RAD51 BRCA2

1.75e-052146217515904
Pubmed

Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.

RAD51 BRCA2

1.75e-052146219875419
Pubmed

Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice.

RAD51 BRCA2

1.75e-052146212619154
Pubmed

The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells.

RAD51 ZGRF1

1.75e-052146232640219
Pubmed

Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.

MDM2 CDC25C

1.75e-052146228806397
Pubmed

Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction.

RAD51 BRCA2

1.75e-052146226992456
Pubmed

BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.

RAD51 BRCA2

1.75e-052146225488918
Pubmed

Bronchiolitis obliterans syndrome is associated with increased p-glycoprotein expression and loss of glucocorticoid receptor from steroid-resistant proinflammatory CD8+ T cells.

NR3C1 ABCB1

1.75e-052146229352737
Pubmed

Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.

RAD51 BRCA2

1.75e-052146225282148
Pubmed

Resistance to therapy caused by intragenic deletion in BRCA2.

RAD51 BRCA2

1.75e-052146218264088
Pubmed

Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2.

RAD51 BRCA2

1.75e-052146237919288
Pubmed

[Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].

RAD51 BRCA2

1.75e-052146219253839
Pubmed

Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction.

RAD51 BRCA2

1.75e-052146232785644
Pubmed

Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.

RAD51 BRCA2

1.75e-052146212442171
Pubmed

A second DNA binding site in human BRCA2 promotes homologous recombination.

RAD51 BRCA2

1.75e-052146227628236
Pubmed

Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction.

RAD51 BRCA2

1.75e-052146223935068
Pubmed

Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.

DMTF1 ABCB1

1.75e-052146224958102
Pubmed

BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents.

RAD51 BRCA2

1.75e-052146235409418
Pubmed

Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2.

RAD51 BRCA2

1.75e-052146214580352
Pubmed

The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype.

RAD51 BRCA2

1.75e-052146227513445
Pubmed

Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

RAD51 BRCA2

1.75e-052146211239456
Pubmed

Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2.

RAD51 BRCA2

1.75e-052146212941707
Pubmed

The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange.

RAD51 BRCA2

1.75e-052146219628690
Pubmed

The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.

RAD51 BRCA2

1.75e-052146219303847
Pubmed

Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression.

RAD51 BRCA2

1.75e-052146218992372
Pubmed

RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.

RAD51 BRCA2

1.75e-05214629405383
Pubmed

Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach.

NR3C1 ABCB1

1.75e-052146234603785
Pubmed

Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer.

MBP VCAN

1.75e-052146215326615
Pubmed

Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.

RAD51 BRCA2

1.75e-052146220729859
Pubmed

The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA.

RAD51 BRCA2

1.75e-052146220729858
Pubmed

Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer.

RAD51 BRCA2

1.75e-052146234302857
Pubmed

Rad51 overexpression rescues radiation resistance in BRCA2-defective cancer cells.

RAD51 BRCA2

1.75e-052146218618591
Pubmed

A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange.

RAD51 BRCA2

1.75e-052146216914443
Pubmed

Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.

MYH9 PCLO MBP ACTN2 CTNNA2 GNB1

2.00e-05131146628634551
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

MYH9 RPGRIP1L SPECC1 SPAG5 KIAA1671 RIF1 ANLN GNB1 ARHGAP21

2.35e-05361146930344098
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CUL4B KDM3B CHAMP1 USP19 RIF1 SAFB PAXBP1 MAP1S ANLN HELZ PHF14 DHX29 ZMYM4

2.50e-057741461315302935
Pubmed

Large-scale concatenation cDNA sequencing.

DMTF1 KIAA0513 GFPT1 FBXL5 CEP350 RIF1 ATAD2B PCDH11X GNB1 DHX29 EPAS1

3.01e-05568146119110174
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CUL4B SETX RPGRIP1L CHD2 ZNF462 PAXBP1 N4BP2 PHF14 GCN1 ZMYM4

3.13e-054691461027634302
Pubmed

A "double adaptor" method for improved shotgun library construction.

DMTF1 KIAA0513 GFPT1 FBXL5 CEP350 RIF1 ATAD2B PCDH11X GNB1 DHX29 EPAS1

3.31e-05574146118619474
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

CUL4B RPGRIP1L GDAP2 DVL3 GIGYF1 SPAG5 KIAA1671 CNNM4 RIF1 KIF3B RABEP1 DOCK7 HELZ LNPK EEA1 CDC25C GCN1

4.22e-0513211461727173435
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

MYH9 LSG1 ICE2 SEC24A GFPT1 EFR3A XRN1 DOCK7 CRYBG3 GCN1 DHX29 ARHGAP21

4.75e-057081461239231216
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CEP350 ZNF462 ABRAXAS2 CNNM4 TSC22D1 N4BP2 FAM169A PHF14 LNPK RIC1

4.75e-054931461015368895
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

SPEG N4BP2 PCDH11X KCNT1 ARHGAP21 RIC1

4.80e-05153146610718198
Pubmed

Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.

RAD51 BRCA2

5.24e-053146215671039
Pubmed

Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.

RAD51 BRCA2

5.24e-053146219549900
Pubmed

FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death.

RAD51 BRCA2

5.24e-053146229789556
Pubmed

DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells.

RAD51 BRCA2

5.24e-053146215359272
Pubmed

Endogenous levels of Rad51 and Brca2 are required for homologous recombination and regulated by homeostatic re-balancing.

RAD51 BRCA2

5.24e-053146224210700
Pubmed

Moonlighting at replication forks - a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51.

RAD51 BRCA2

5.24e-053146228079255
InteractionKRT8 interactions

MYH9 MIA3 RPGRIP1L LSG1 SPAG5 CEP350 KIAA1671 CEP89 ANLN RABEP1 N4BP2 ZNF804B DOCK7 HELZ AKAP11 CRYBG3 ARHGAP21

1.46e-0844114217int:KRT8
InteractionCEP135 interactions

MIA3 RPGRIP1L DVL3 GIGYF1 CEP350 KIAA1671 BRCA2 CEP250 XRN1 HERC2 ARHGAP21 ZMYM4

5.27e-0727214212int:CEP135
InteractionPFN1 interactions

RAD51 MYH9 DOCK8 PCLO SPAG5 GGA3 CEP350 KIAA1671 KIF3B ANLN RABEP1 N4BP2 DOCK7 CRYBG3 ARHGAP21 ZMYM4

6.31e-0750914216int:PFN1
InteractionKDM1A interactions

RAD51 MYH9 RPGRIP1L ZGRF1 DVL3 NR3C1 CHAMP1 DNAJC6 SPAG5 CEP350 KIAA1671 ZNF462 BRCA2 RABEP1 N4BP2 XRN1 DOCK7 CRYBG3 GCN1 ARHGAP21 EPAS1 ZMYM4

7.18e-0794114222int:KDM1A
InteractionKIF20A interactions

OTOA MYH9 SETX GDAP2 PCLO CHD2 ACTN2 SPECC1 EFR3A MSRB3 KIAA1671 ZNF462 SAFB PAXBP1 MLIP ANLN RABEP1 XRN1 HELZ CRYBG3 HERC2 GNB1 GCN1

1.24e-06105214223int:KIF20A
InteractionNIN interactions

MIA3 RPGRIP1L GFPT1 SPAG5 CEP350 KIAA1671 PPP2R3A BRCA2 ANLN CEP250 XRN1 HERC2 ARHGAP21

1.61e-0635914213int:NIN
InteractionRCOR1 interactions

RAD51 CUL4B MYH9 ZGRF1 DVL3 NR3C1 DNAJC6 BRCA2 RABEP1 XRN1 FAM169A DOCK7 GCN1 ARHGAP21 ZMYM4

2.22e-0649414215int:RCOR1
InteractionYWHAH interactions

SETX RPGRIP1L LSG1 KIAA0232 SEC24A SPEG KDM3B GIGYF1 NR3C1 SPECC1 ANKRD55 CEP350 KIAA1671 CEP89 ANLN RABEP1 XRN1 DOCK7 AKAP11 CRYBG3 CDC25C SUCO ARHGAP21

2.71e-06110214223int:YWHAH
InteractionYWHAQ interactions

MYH9 RPGRIP1L SEC24A SPEG GIGYF1 ACTN2 MDM2 SPECC1 ITGB4 ANKRD55 CEP350 KIAA1671 CEP89 ANLN RABEP1 CEP250 DOCK7 AKAP11 ZCCHC7 CDC25C SUCO GCN1 ARHGAP21

3.44e-06111814223int:YWHAQ
InteractionPHF21A interactions

RAD51 CUL4B ZGRF1 DVL3 SPAG5 KIAA1671 BRCA2 RABEP1 XRN1 DOCK7 CRYBG3 ARHGAP21

5.86e-0634314212int:PHF21A
InteractionCLTA interactions

MYH9 MIA3 DOCK8 NR3C1 DNAJC6 GGA3 KIAA1671 ANLN RABEP1 XRN1 EEA1 HERC2

7.40e-0635114212int:CLTA
InteractionNUP43 interactions

RAD51 SETX CHAMP1 SPAG5 MSRB3 ZNF462 RIF1 SAFB FBN1 PAXBP1 BRCA2 CEP250 ATAD2B FAM169A ZCCHC7 ZMYM4

8.81e-0662514216int:NUP43
InteractionHDAC1 interactions

RAD51 CUL4B MYH9 ZGRF1 DVL3 NR3C1 MDM2 DNAJC6 USP19 SPAG5 KIAA1671 BRCA2 ANLN RABEP1 CEP250 XRN1 DOCK7 PHF14 CRYBG3 GCN1 ARHGAP21 EPAS1

1.01e-05110814222int:HDAC1
InteractionRNF43 interactions

MIA3 SEC24A DVL3 GIGYF1 GGA3 KIAA1671 ABRAXAS2 XRN1 HELZ CRYBG3 GCN1 ATP2B3 ARHGAP21

1.06e-0542714213int:RNF43
InteractionYWHAZ interactions

RAB11B MYH9 RPGRIP1L KIAA0232 SEC24A SPEG MBP GIGYF1 MDM2 SPECC1 FAM13B ANKRD55 SPAG5 KIAA1671 CEP89 ANLN RABEP1 DOCK7 AKAP11 ZCCHC7 HERC2 CDC25C SUCO ARHGAP21

1.63e-05131914224int:YWHAZ
InteractionYWHAG interactions

RAB11B RPGRIP1L KIAA0232 SEC24A SPEG KDM3B GIGYF1 SPECC1 FAM13B ANKRD55 CEP350 KIAA1671 CEP89 ANLN RABEP1 N4BP2 CEP250 DOCK7 HELZ AKAP11 CDC25C SUCO ARHGAP21

2.05e-05124814223int:YWHAG
InteractionCEP162 interactions

MYH9 RPGRIP1L SYBU KIAA1671 ABRAXAS2 CEP89 ANLN HERC2

2.57e-051681428int:CEP162
InteractionCDH1 interactions

RAB11B PAG1 MYH9 DVL3 MDM2 SPECC1 GGA3 EFR3A KIAA1671 GPR61 ANLN XRN1 CTNNA2 KDF1 GCN1 DHX29 ARHGAP21

2.96e-0576814217int:CDH1
InteractionSFN interactions

KIAA0232 GIGYF1 NR3C1 MDM2 SPECC1 CEP350 KIAA1671 CEP89 ANLN DOCK7 AKAP11 CRYBG3 EEA1 ZCCHC7 CDC25C ARHGAP21

3.07e-0569214216int:SFN
InteractionOFD1 interactions

RAB11B RPGRIP1L ICE2 GIGYF1 SPAG5 CEP350 KIAA1671 CEP89 ANLN RABEP1 XRN1

3.60e-0534714211int:OFD1
InteractionVASP interactions

RAD51 CUL4B SEC24A SPAG5 CEP350 KIAA1671 RABEP1 CEP250 LRP4 ARHGAP21

4.57e-0529414210int:VASP
InteractionFLNA interactions

RAD51 CUL4B MYH9 ZGRF1 PHOSPHO2 CHD2 SPECC1 ANKRD55 USP19 GGA3 BRCA2 ANLN SIGLEC10 CDC25C ARHGAP21

5.43e-0564814215int:FLNA
InteractionCHMP4B interactions

RAB11B MYH9 KDM3B ACTN2 SPECC1 GFPT1 MSRB3 KIAA1671 MLIP BRCA2 ANLN AKAP11 HERC2 GNB1 GCN1 ARHGAP21

5.52e-0572714216int:CHMP4B
InteractionNAA40 interactions

MYH9 LSG1 KDM3B NR3C1 CHAMP1 GFPT1 SPAG5 GGA3 KIAA1671 RIF1 SAFB RABEP1 XRN1 FAM169A HELZ KDF1 GCN1 DHX29 ARHGAP21

5.80e-0597814219int:NAA40
InteractionBICD1 interactions

KIAA0232 SYBU GGA3 KIAA1671 PPP2R3A ANLN N4BP2 XRN1 HERC2

7.18e-052501429int:BICD1
InteractionPPP2R1A interactions

RAD51 MYH9 NR3C1 DNAJC6 FAM13B ANKRD55 GFPT1 EFR3A CEP350 RIF1 PPP2R3A ANLN CTNNA2 POLN CDC25C

7.26e-0566514215int:PPP2R1A
InteractionNCKAP5 interactions

CEP350 KIF3B BRCA2 HERC2

7.29e-05321424int:NCKAP5
InteractionGSK3A interactions

CUL4B MIA3 LSG1 LRRC37A2 SPAG5 CEP350 KIAA1671 RABEP1 DOCK7 AKAP11 CRYBG3 ARHGAP21

1.12e-0446414212int:GSK3A
InteractionZYX interactions

CUL4B SPAG5 CEP350 KIAA1671 RABEP1 N4BP2 HELZ AKAP11 CRYBG3 ARHGAP21

1.16e-0432914210int:ZYX
InteractionGOLGA6L2 interactions

RAD51 NR3C1 BRCA2 AKAP11

1.17e-04361424int:GOLGA6L2
InteractionDYRK1A interactions

DCHS2 ICE2 KIAA0232 DVL3 MDM2 ITGB4 GGA3 FBN1 ANLN XRN1 DOCK7 LRP4 AKAP11

1.47e-0455214213int:DYRK1A
InteractionWTIP interactions

NR3C1 PPP2R3A BRCA2

1.79e-04161423int:WTIP
InteractionSSX2IP interactions

RPGRIP1L DVL3 ACTN2 CEP350 KIAA1671 CEP89 CEP250 XRN1 HERC2

2.09e-042881429int:SSX2IP
Cytoband17q25.1

SDK2 CD300H CD300C GGA3

1.35e-0481146417q25.1
CytobandEnsembl 112 genes in cytogenetic band chr5q31

PCDHGA9 SEC24A KDM3B NR3C1 FAM13B CDC25C

4.03e-042981466chr5q31
Cytoband5q31

PCDHGA9 KDM3B FAM13B CDC25C

5.16e-0411514645q31
Cytoband2q31

FASTKD1 LNPK

7.66e-041314622q31
GeneFamilyUPF1 like RNA helicases

SETX ZGRF1 HELZ

2.25e-05119531169
GeneFamilyPDZ domain containing

FRMPD4 PCLO DVL3 HTRA3 ARHGAP21

1.24e-031529551220
GeneFamilyFibronectin type III domain containing

SDK2 PTPRU ITGB4 FSD1L TNR

1.56e-03160955555
GeneFamilyRho GTPase activating proteins|BCH domain containing

ARHGAP30 FAM13B ARHGAP21

2.30e-0350953721
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

RPGRIP1L PPP1R3B PCDH11X AKAP11 CDC25C

2.67e-03181955694
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

MIA3 FRMPD4 SPEG PCLO SYBU GIGYF1 DNAJC6 TENM2 ZNF462 SLC39A12 PPP2R3A N4BP2 VCAN PCDH11X FAM169A ANKRD36 ANKRD12 CTNNA2 EEA1 ICA1L

3.17e-06110614520M39071
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

CUL4B GGNBP2 SETX ICE2 SPECC1 FAM13B CEP350 RIF1 PPP2R3A ANLN RABEP1 AKAP11 EEA1 SUCO DHX29

3.82e-0665614515M18979
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

SETX SEC24A KDM3B NR3C1 EFR3A CEP350 RIF1 PPP2R3A BRCA2 ATAD2B FAM169A HELZ PHF14 AKAP11 CRYBG3 SUCO ZMYM4

5.49e-0685614517M4500
CoexpressionGSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN

CUL4B GGNBP2 MIA3 SPECC1 RIF1 SAFB RABEP1 ATAD2B

1.63e-052001458M391
CoexpressionGSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP

MYNN MDM2 CEP350 CNNM4 PAXBP1 XRN1 PHF14

3.16e-051601457M339
CoexpressionPHONG_TNF_RESPONSE_VIA_P38_COMPLETE

SEC24A PCLO MBP NR3C1 GFPT1 FBXL5 GOLPH3L VCAN

3.67e-052241458M2500
CoexpressionMARKEY_RB1_ACUTE_LOF_UP

RAD51 MDM2 FAM13B TSC22D1 BRCA2 ANLN VCAN CDC25C

5.46e-052371458M15606
CoexpressionMARKEY_RB1_ACUTE_LOF_UP

RAD51 MDM2 FAM13B TSC22D1 BRCA2 ANLN VCAN CDC25C

5.96e-052401458MM976
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

RPGRIP1L DOCK8 CEP350 CNNM4 RIF1 ATAD2B RIC1

6.67e-051801457M8239
CoexpressionMURARO_PANCREAS_BETA_CELL

MIA3 SPEG PCLO MBP SYBU NR3C1 MDM2 DNAJC6 GFPT1 EFR3A KIF3B RABEP1 AKAP11 ANKRD12 LNPK SUCO

7.29e-0594614516M39169
CoexpressionGSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN

DMTF1 MIA3 SETX DOCK8 CD300C HERC2 EPAS1

1.25e-041991457M316
CoexpressionGSE43955_1H_VS_42H_ACT_CD4_TCELL_DN

DMTF1 DAPK2 HTRA3 FBXL5 FBN1 VCAN SLC10A6

1.29e-042001457M9665
CoexpressionGSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP

RAD51 ACTN2 TENM2 BRCA2 ANLN VCAN CDC25C

1.29e-042001457M8527
CoexpressionGSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN

MYH9 KDM3B ARHGAP30 GIGYF1 SAFB LNPK GNB1

1.29e-042001457M7436
CoexpressionGSE17721_0.5H_VS_4H_POLYIC_BMDC_DN

CUL4B NR3C1 GFPT1 EFR3A TSC22D1 VCAN ATAD2B

1.29e-042001457M4091
CoexpressionFAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON

PCLO SYBU ACTN2 ICA1L

1.33e-04471454M39019
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP

CUL4B DMTF1 MIA3 SETX ICE2 SEC24A FASTKD1 KDM3B NR3C1 ABCB1 EFR3A CEP350 ABRAXAS2 TSC22D1 ATAD2B EEA1 GNB1 ZMYM4

1.36e-04121514518M41122
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000

PAG1 SETX MYNN GFPT1 SPAG5 EFR3A MSRB3 CEP350 VCAN PCDH11X HERC2 SUCO GCN1 ZMYM4

1.76e-0736914114DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500

PAG1 SETX GFPT1 EFR3A MSRB3 CEP350 VCAN HERC2 GCN1

6.10e-061941419DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000

IQSEC3 PPP1R3B PCLO MBP CHD2 PTPRU NR3C1 SPECC1 SPAG5 CEP350 RIF1 FSD1L SAFB BRCA2 RABEP1 ATAD2B PCDH11X FAM169A LRP4 PHF14

7.99e-0698314120Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

ICE2 CHD2 SPAG5 RIF1 SAFB BRCA2 RABEP1 ATAD2B PHF14 ARHGAP21

4.47e-0531114110Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#3

PPP1R3B NR3C1 TENM2 PCDH11X KDF1

4.51e-05591415Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K3
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000

PAG1 MYH9 SETX SPEG MYNN EFR3A CEP350 VCAN PCDH11X GCN1

4.60e-0531214110gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000

PAG1 MYH9 SETX MYNN EFR3A MSRB3 CEP350 VCAN HERC2 GCN1 ZMYM4

5.41e-0538514111gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000

PAG1 SETX GFPT1 EFR3A MSRB3 CEP350 VCAN PCDH11X HERC2 SUCO GCN1

7.12e-0539714111gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000

PAG1 SETX GFPT1 EFR3A CEP350 RIF1 VCAN PCDH11X HERC2 SUCO

7.34e-0533014110DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlasDevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500

MYH9 FASTKD1 PHOSPHO2 EFR3A MSRB3 GCN1

7.62e-051061416gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500

PAG1 SETX TENM2 GFPT1 EFR3A MSRB3 CEP350 VCAN PCDH11X HERC2 GCN1

9.08e-0540814111DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000

PAG1 SETX PPP1R3B MYNN TENM2 GFPT1 SPAG5 EFR3A MSRB3 CEP350 VCAN PCDH11X HERC2 SUCO GCN1 ZMYM4

9.24e-0580614116DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000

PAG1 MYH9 SETX MYNN DNAJC6 TENM2 EFR3A MSRB3 CEP350 ZNF462 VCAN DGKK PCDH11X HERC2 GCN1 ZMYM4

1.10e-0481814116gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlascerebral cortex

IQSEC3 FRMPD4 KIAA0513 PCDHGA9 PCLO MBP SYBU DNAJC6 TENM2 KCNK4 SLC39A12 FSD1L GPR61 ANLN PCDH11X FAM169A LRP4 UNC13C CTNNA2 TNR ATP2B3 KCNT1

1.84e-04142814122cerebral cortex
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

SETX PCLO SPAG5 RIF1 SAFB BRCA2 ANLN RABEP1 N4BP2 FAM169A LRP4 LNPK

2.30e-0453214112Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasdev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000

CUL4B FASTKD1 ZNF462 N4BP2 FAM169A

2.44e-04841415gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000

RAB11B GANC PPP1R3B ICE2 GDAP2 PCLO CHD2 ACTN2 MDM2 CNNM4 PPP2R3A BRCA2 CEP89 ATAD2B PHF14 AKAP11 RIC1

2.93e-0498514117Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000

ICE2 PCLO CHD2 ACTN2 TENM2 SPAG5 CNNM4 RIF1 FSD1L SAFB BRCA2 RABEP1 ATAD2B PCDH11X FAM169A PHF14 ARHGAP21

3.08e-0498914117Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlasDevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000

MYH9 SETX DOCK8 PTPRU MSRB3

3.54e-04911415DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000

PAG1 SETX DNAJC6 TENM2 GFPT1 EFR3A MSRB3 CEP350 ZNF462 RIF1 VCAN DGKK PCDH11X HERC2 SUCO

3.61e-0481814115DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

RAD51 CUL4B SETX ZGRF1 ICE2 FBXL5 RIF1 BRCA2 ANLN DGKK FAM169A HELZ AKAP11 ANKRD12 NLRP4

3.71e-0482014115gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500

SETX GFPT1 MSRB3 VCAN PCDH11X

3.72e-04921415DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

RPGRIP1L GANC PCLO CHD2 MYNN SPAG5 RIF1 SAFB BRCA2 CEP89 RABEP1 CEP250 PHF14 EEA1 ARHGAP21

4.26e-0483114115Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlasDevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_500

SETX DOCK8 MSRB3

4.60e-04231413gudmap_developingKidney_e15.5_Endothelial cells_500_k1
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SETX DOCK8 CHD2 CEP350 PAXBP1 ATAD2B XRN1 HELZ ANKRD12

2.16e-08200146912f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellCV-Healthy-3|CV / Virus stimulation, Condition and Cluster

KIAA0513 PPP1R3B ITGB4 CCDC7 PAXBP1 GOLPH3L CRYBG3 EPAS1

6.26e-081611468fd4a79385ea967b9900dc76a3add813b894a3a28
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

PAG1 SPEG MBP CHD2 ACTN2 LRRC37A ANKRD12

1.10e-061621467b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PAG1 ZGRF1 SPECC1 FBN1 BRCA2 ANLN VCAN

1.58e-061711467b0373ed8283ee1792b6a490bff93906546978593
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PAG1 ZGRF1 SPECC1 FBN1 BRCA2 ANLN VCAN

1.58e-061711467b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 PTPRU ABCB1 MLIP PCDH11X CRYBG3

1.98e-0617714674c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CYB5RL CFI ITGB4 ZBBX FBN1 SLC10A6 EPAS1

2.38e-061821467d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ANKRD55 ZNF462 TSC22D1 VCAN LRP4 ANKRD36 TNR

4.30e-06199146719a97e27a4758e794ce7246d295e112b47931a48
ToppCellCV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster

PPP1R3B ITGB4 CCDC7 PAXBP1 CRYBG3 EPAS1

1.19e-05154146626bf81a86700db7e65c2384ffe94ed4253ea4047
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

2.02e-051691466e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

RAD51 SPAG5 SLC39A12 BRCA2 ANLN CDC25C

2.16e-0517114664ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RAD51 SPAG5 SLC39A12 BRCA2 ANLN CDC25C

2.46e-0517514660b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HTRA3 NR3C1 CEP350 PAXBP1 XRN1 ARHGAP21

2.54e-051761466749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells)

ZGRF1 SPAG5 BRCA2 ANLN SIGLEC10 CDC25C

2.62e-051771466ba701d3c90722d8bff70d0fa651899305cdad257
ToppCellfacs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DVL3 ITGB4 TENM2 CNNM4 LRP4 GNB1

2.79e-0517914668001db3044e8657980e24422377c4fdb0d7b323e
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Signet-6|TCGA-Stomach / Sample_Type by Project: Shred V9

DCHS2 MYNN MDM2 CNNM4 MAP1S

2.86e-051081465cac2108956e0c7b0326b8bf75033528eb1025480
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 PTPRU ABCB1 PCDH11X CRYBG3

2.88e-051801466b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

2.88e-051801466334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 PTPRU ABCB1 PCDH11X CRYBG3

2.97e-05181146608f44323bf71b6004a921bbc969c954c75feeb66
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-051841466a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-051841466081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCellControl-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-05184146645f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA FRMPD4 PCLO DGKK PCDH11X UNC13C

3.25e-0518414662cbed6462fea2622871bb7e49b0df3d984239281
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-05184146684c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SETX DOCK8 NR3C1 CEP350 XRN1 ZCCHC7

3.25e-0518414661154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellPBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-051841466d31d4116d1d196633784863781fa45673607a421
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA FRMPD4 PCLO DGKK PCDH11X UNC13C

3.25e-051841466ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA FRMPD4 PCLO DGKK PCDH11X UNC13C

3.25e-0518414662b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellControl-immature_Neutrophil-|Control / Disease condition and Cell class

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-051841466c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCellControl-immature_Neutrophil|Control / Disease condition and Cell class

ICE2 DAPK2 FASTKD1 SPAG5 ANLN LNPK

3.25e-0518414662fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

MYH9 DAPK2 ACTN2 MSRB3 TSC22D1 MLIP

3.67e-0518814666d249fe92d51a19da19ec14bb2262d394255d577
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

HTRA3 FBN1 KIF3B VCAN CEP250 PHF14

3.67e-05188146614bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

3.78e-0518914661e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

4.01e-051911466e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

CUL4B EFR3A CEP350 N4BP2 CRYBG3 ZMYM4

4.25e-051931466abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SYBU SPECC1 ITGB4 FBN1 PCDH11X EPAS1

4.25e-0519314662e72309607902dabe3218888b22a77fe941f3570
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HTRA3 MSRB3 FBN1 BRCA2 ANLN LNPK

4.25e-051931466ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HTRA3 MSRB3 FBN1 BRCA2 ANLN LNPK

4.37e-05194146623318a1b55895b5166c6151f488a94a09b4627ff
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

DAPK2 ACTN2 TENM2 MSRB3 PPP2R3A MLIP

4.37e-051941466c3535f7cc0076653c72db582047cff053c322397
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PAG1 KIAA0513 DOCK8 CD300C VCAN SIGLEC10

4.50e-0519514661d58585557bf8e9ce4d514e128d3a902b526331d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PAG1 DOCK8 ARHGAP30 CD300C VCAN SIGLEC10

4.50e-05195146610ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCellsystemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SETX ARHGAP30 CHD2 XRN1 ANKRD36 ANKRD12

4.90e-0519814664c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

4.90e-051981466b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCellSigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass

PCDHGA9 ANKRD55 SLC26A8 XRN1 ANKRD36 DHX29

4.90e-051981466305d7ae9b070ac7211638a5282374c02bf13af40
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X

MYH9 SPEG ACTN2 MSRB3 TSC22D1 EPAS1

4.90e-05198146689986c7756541df364df516329d10775ba0e78a4
ToppCellprimary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FRMPD4 PCLO SYBU TENM2 TSC22D1 ANKRD36

4.90e-0519814666d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass

MYH9 SPEG MSRB3 KIAA1671 TSC22D1 EPAS1

5.03e-051991466d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

PCLO SYBU ANLN PCDH11X UNC13C ANKRD12

5.03e-0519914661b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MBP TSC22D1 FBN1 VCAN PCDH11X PHF14

5.03e-051991466da016849b804fbf80edbfa8f8f56c9df8bbf2d51
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

PCLO SPECC1 CEP350 ANKRD36 ANKRD12 EEA1

5.03e-051991466c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell(02)_MMP9/10+|World / shred by cell type by condition

MYH9 SDK2 ITGB4 TENM2 MSRB3 VCAN

5.03e-0519914663f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

PCLO SYBU ANLN PCDH11X UNC13C ANKRD12

5.03e-0519914664bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCellLPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ZGRF1 SPAG5 BRCA2 ANLN CTNNA2 CDC25C

5.03e-05199146698575fcce726589e93fbb4df1aab03e57cb56076
ToppCellLPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

5.03e-051991466be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

5.18e-0520014664cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type.

NBPF3 GANC MBP CHAMP1 ZBBX GOLPH3L

5.18e-052001466401d50fa394fa863fa7836344110ae5c7af3250a
ToppCellControl_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

5.18e-0520014669bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCellBL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RAD51 ZGRF1 SPAG5 BRCA2 ANLN CDC25C

5.18e-05200146604d95a9102248e98eed069840ea6d3d23a243fd5
ToppCellGlobus_pallidus|World / BrainAtlas - Mouse McCarroll V32

DCHS2 MBP N4BP2 DGKK UNC13C

5.98e-05126146544b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCellLPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRMPD4 PCLO PTPRU ANKRD55 LRP4

6.21e-0512714656b24630978eb0772b4cd3bf59e5bc4390be47619
ToppCelldroplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PAG1 GGNBP2 ZGRF1 FASTKD1 GFPT1

8.59e-051361465a43b3db1754c619d328a26a2ba6af4756629a723
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SPEG PTPRU BRCA2 ANLN TNR

1.12e-041441465f6061dd965a2b2fe6ad864f8aecc06d2e74881ce
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

DCHS2 MIA3 ZBBX EFR3A KDF1

1.12e-04144146508005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SPAG5 ZBBX FSD1L ANLN KDF1

1.41e-041511465c06a54afe918b14f885d6a85fbcf81e80f33afae
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PTPRU SYTL5 ANLN PCDH11X UNC13C

1.59e-0415514655c7b68b59244525e3714806c205a57a2daebf423
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGAP30 CHAMP1 GFPT1 CNNM4 ZNF18

1.69e-041571465a93866f051472506f1468f379c0d5313e02c9731
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IQSEC3 FRMPD4 CD300C MLIP ZNF804B

1.89e-04161146569f5e759c0925daa37e0177a9cc3154842906bf6
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DAPK2 PHOSPHO2 SYBU GOLPH3L RP1

1.95e-0416214655c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZGRF1 SPAG5 BRCA2 ANLN CDC25C

2.01e-0416314655285318c52aa31c9b22dc2ffff078e32e408604d
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IQSEC3 FRMPD4 CD300C MLIP ZNF804B

2.12e-0416514656d8b5669eee9b0903c9260fea707d186c9d7fefa
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHGA9 LSG1 GOLPH3L SYTL5 TNR

2.12e-0416514651703d3eb644b3c743ad3c5532b1d29ea010c79c8
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IQSEC3 FRMPD4 CD300C MLIP ZNF804B

2.12e-04165146502cd87dfa2ca40e13455a4b9308477e82f76289b
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPEG ACTN2 DNAJC6 MSRB3 KCNT1

2.12e-0416514658a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells)

RAD51 IQSEC3 SPAG5 BRCA2 MS4A14

2.24e-0416714657efa0081e79f22b219eac64ffcaedb2179cde299
ToppCelldroplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51 ZGRF1 SPECC1 BRCA2 POLN

2.24e-041671465bad33497ceeab968a7eb8a48b921c6f936390743
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HTRA3 MSRB3 FBN1 VCAN KCNT1

2.31e-0416814654b2d29a7843bf45922038c093ca7ec0600756adc
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAD51 ZGRF1 BRCA2 ANLN CDC25C

2.37e-0416914650bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCelldroplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DPH7 ACTN2 CEP250 XRN1 ARHGAP21

2.37e-041691465d721dbb317a88113b4f76688111908d00f23e899
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HTRA3 MSRB3 FBN1 VCAN KCNT1

2.50e-0417114655d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCelldroplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51 DAPK2 CHAMP1 SPAG5 CEP89

2.57e-041721465e495efd25aec60b97ac2b5aa861651bd73174a17
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCST1 ANLN ZCCHC7 POLN ICA1L

2.64e-041731465a5b6c3d58f7a8e533330798b81496009a31548af
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCST1 ANLN ZCCHC7 POLN ICA1L

2.64e-041731465cc094992b8027f4cef38f0fb0b76f0d07210d1e2
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPEG ACTN2 DNAJC6 MSRB3 KCNT1

2.64e-0417314655416b092321c7d9b63f0418c60f2402a138355bf
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 ABCB1 VCAN PCDH11X

2.71e-041741465912a9e892b29d945666fc37c986009c97c668ac8
ToppCellASK452-Immune-B_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

IQSEC3 LRRC37A2 PTPRU SPAG5 DOCK7

2.71e-04174146569723f5666abc3af5f0431901a60246c9915ef81
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 ABCB1 MLIP PCDH11X

2.71e-041741465e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 PTPRU KIAA1671 PCDH11X CRYBG3

2.71e-04174146599eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells)

RAD51 ZGRF1 PCLO CNNM4 SLC10A5

2.79e-041751465fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCellDividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

RAD51 SPAG5 BRCA2 ANLN CDC25C

2.79e-0417514650a8bf455babb3271aa00642199fb58b0b02dc3ac
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZGRF1 BRCA2 ANLN UNC13C CDC25C

2.79e-041751465876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SPAG5 BRCA2 ANLN FAM169A CDC25C

2.79e-0417514656b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells)

RAD51 ZGRF1 PCLO CNNM4 SLC10A5

2.79e-04175146536c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

IQSEC3 SEC24A HTRA3 CNNM4 PHF14

2.86e-041761465bd5c85b3a4fb88ffe156599f6d224aa7664a513a
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RAD51 FRMPD4 KCNK4 BRCA2 VCAN

2.86e-041761465cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPAG5 CEP89 ANLN CDC25C EPAS1

2.86e-0417614658385435074cc5235b7af7424974f609388fc2cff
ToppCell3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

OTOA DOCK8 CCDC7 SIGLEC10 TRPV3

2.94e-041771465b326376e879afef579b1b7094d756aaff0de270b
ToppCell3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

OTOA DOCK8 CCDC7 SIGLEC10 TRPV3

2.94e-041771465393882f1bf7658a17e10a771b803339f16fb2e69
ToppCell3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue

FSD1L PPP2R3A ICA1L ARHGAP21 EPAS1

2.94e-04177146553040dbeb18574a48e352e4bce252c7c3018762c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 PTPRU ABCB1 PCDH11X

2.94e-041771465bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 SDK2 PTPRU ABCB1 CRYBG3

3.01e-041781465431e7557b8e8764e16e9e48368ce6bfa3c61561a
DiseaseIntellectual Disability

RAB11B IQSEC3 FRMPD4 DOCK8 KDM3B CHAMP1 KCNK4 ZNF462 CTNNA2 LNPK GNB1

1.15e-0544714211C3714756
DiseaseGlobal developmental delay

FRMPD4 KDM3B ZNF462 CTNNA2 LNPK GNB1

4.64e-051331426C0557874
DiseaseMalignant neoplasm of breast

RAD51 MYH9 LRRC37A2 DVL3 MDM2 GGA3 ABCB1 CNNM4 RIF1 SLC39A12 LRRC37A BRCA2 N4BP2 SLC10A6 HERC2

2.17e-04107414215C0006142
Diseaseatrophic macular degeneration

KIAA0513 MBP CFI

2.32e-04251423EFO_1001492
Diseasesleep duration

KDM3B ARHGAP30 NR3C1 TENM2 PPP2R3A ZCCHC7 CDC25C ZMYM4

3.83e-043621428EFO_0005271
Diseasesusceptibility to scarlet fever measurement

SDK2 PPP2R3A ANKRD12 LNPK

5.84e-04791424EFO_0008409
Diseasegeneralized anxiety disorder (implicated_via_orthology)

NR3C1 ZNF462

6.32e-0481422DOID:14320 (implicated_via_orthology)
Diseasehippocampus molecular layer volume

MSRB3 ABRAXAS2 VCAN

6.38e-04351423EFO_0009397
Diseaseencephalitis (biomarker_via_orthology)

MBP ABCB1

8.10e-0491422DOID:9588 (biomarker_via_orthology)
Diseaseunipolar depression, bipolar disorder

DMTF1 PCLO TENM2 CNNM4 ZCCHC7

9.70e-041561425EFO_0003761, MONDO_0004985
DiseaseBreast Carcinoma

RAD51 MYH9 LRRC37A2 MDM2 ABCB1 LRRC37A BRCA2 SLC10A6 HERC2

1.22e-035381429C0678222
Diseasemaleate measurement, Alpha ketoglutarate measurement, fumarate measurement

EFR3A PHF14

1.23e-03111422EFO_0010457, EFO_0010480, EFO_0010509
Diseaseanti-thyroglobulin antibody measurement

IQSEC3 RPGRIP1L NLRP4

1.42e-03461423EFO_0009896
DiseaseParkinson's disease symptom measurement

CD300H CD300C XRN1

1.61e-03481423EFO_0600011
Diseasehippocampal CA1 volume

MSRB3 ABRAXAS2 VCAN

1.61e-03481423EFO_0009394
Diseaseamyloid-beta measurement

MBP CHD2 TENM2 EFR3A RP1 CTNNA2 LNPK

1.71e-033551427EFO_0005194
DiseaseL2 Acute Lymphoblastic Leukemia

PAG1 ABCB1 GNB1

1.81e-03501423C0023453
DiseaseHereditary Breast and Ovarian Cancer Syndrome

RAD51 BRCA2

2.01e-03141422C0677776
DiseaseChildhood Acute Lymphoblastic Leukemia

PAG1 ABCB1 GNB1

2.03e-03521423C0023452
DiseaseHMG CoA reductase inhibitor use measurement

MIA3 BRCA2 DOCK7 RP1 KDF1

2.26e-031891425EFO_0009932
DiseaseMyasthenic Syndromes, Congenital, Slow Channel

GFPT1 LRP4

2.64e-03161422C0751885
Diseaseureidopropionic acid measurement

PAG1 RPGRIP1L

2.64e-03161422EFO_0010542
Diseasemean corpuscular hemoglobin concentration

ATMIN RAB11B LRRC37A2 DVL3 MYNN GIGYF1 MDM2 SPECC1 RIF1 SLC26A8 ATAD2B ANKRD12 ARHGAP21

2.69e-03110514213EFO_0004528
Diseaseneutrophil percentage of leukocytes

DOCK8 LSG1 MYNN NR3C1 PPP2R3A FBN1 GOLPH3L HELZ AKAP11

2.86e-036101429EFO_0007990
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

PCLO KDM3B TENM2 CNNM4 ZCCHC7

2.88e-032001425EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
DiseaseCongenital Myasthenic Syndromes, Postsynaptic

GFPT1 LRP4

2.98e-03171422C0751883
Diseaseerythrocyte cadmium measurement

MBP SUCO

2.98e-03171422EFO_0007807
DiseaseAstrocytosis

ITGB4 TNR

2.98e-03171422C3887640
DiseaseGliosis

ITGB4 TNR

2.98e-03171422C0017639
DiseasePrecursor Cell Lymphoblastic Leukemia Lymphoma

PAG1 ABCB1 GNB1

3.20e-03611423C1961102
Diseasenephrotic syndrome (is_marker_for)

NR3C1 CFI

3.35e-03181422DOID:1184 (is_marker_for)
Diseaseresponse to clozapine

SLC39A12 CTNNA2

3.35e-03181422GO_0097338
DiseaseCongenital Myasthenic Syndromes, Presynaptic

GFPT1 LRP4

3.73e-03191422C0751884
Diseasecerebral microbleeds

ABCB1 CTNNA2

3.73e-03191422EFO_0010059
Diseaseresponse to paliperidone, schizophrenia symptom severity measurement

ANKRD55 TENM2 ZBBX OSCP1 POLN

4.00e-032161425EFO_0007925, EFO_0007927
DiseaseMammary Carcinoma, Human

RAD51 MYH9 LRRC37A2 MDM2 ABCB1 LRRC37A BRCA2 SLC10A6

4.01e-035251428C4704874
DiseaseMammary Neoplasms, Human

RAD51 MYH9 LRRC37A2 MDM2 ABCB1 LRRC37A BRCA2 SLC10A6

4.01e-035251428C1257931
DiseaseMammary Neoplasms

RAD51 MYH9 LRRC37A2 MDM2 ABCB1 LRRC37A BRCA2 SLC10A6

4.10e-035271428C1458155
DiseaseSeizures

CUL4B KDM3B KCNK4 LNPK GNB1

4.16e-032181425C0036572
Diseaseresponse to ketamine

DOCK8 NR3C1 KIAA1671

4.53e-03691423EFO_0009748
DiseaseBREAST CANCER

RAD51 BRCA2

4.55e-03211422114480
Diseasechronic myeloid leukemia (is_implicated_in)

MDM2 ABCB1

4.55e-03211422DOID:8552 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
STQTDFNELDLETLA

EPAS1

516

Q99814
FASVTQEETEILTAD

CFI

296

P05156
EVRQEETFSISDSQI

ABRAXAS2

31

Q15018
ETADTDTAEQVIASF

ACTN2

821

P35609
EQTIFDSQTFTETEL

VCAN

2136

P13611
DESAFLESSNEVSVA

CCDC7

506

Q96M83
LDTTQDSDQETTNLL

CRYBG3

201

Q68DQ2
RTAETELTSTNFQDV

ADGRG4

521

Q8IZF6
STAEELQATLQELSD

SPECC1

386

Q5M775
TNQSVSSIEDDFVTA

AKAP11

176

Q9UKA4
DDLDDIIQSSQTVSE

ANKRD36

1326

A6QL64
REEDTSEVNDIITTF

ANKRD55

371

Q3KP44
SIEDEESQQSILSSL

ANKRD12

1681

Q6UB98
NLVSDEDFSALSLES

DHX29

526

Q7Z478
QENLDNDTETDSLVS

DVL3

126

Q92997
QAELTVDSDIQSSDF

DMTF1

586

Q9Y222
SDDVVSNTEEITFEA

EFR3A

716

Q14156
EASDIILTDDNFTSI

ATP2B3

821

Q16720
LSFTVTLENLTEEDA

CD300C

91

Q08708
QESERDDVFSTLTSQ

POLN

646

Q7Z5Q5
LEDNSDLFSEQDVTV

MLIP

361

Q5VWP3
IETSALDSTNVEEAF

RAB11B

151

Q15907
ALTQEESSAQLSNEE

RABEP1

351

Q15276
QLEANADTSVEEESF

RAD51

6

Q06609
VDENFSTLSLTQSEL

RIC1

1231

Q4ADV7
NQSTESTQDEETLAL

KIAA0513

81

O60268
EATSALDTESEAVVQ

ABCB1

556

P08183
NESELEQLDLSSIDT

OTOA

911

Q7RTW8
ELNSSDTTAEIFQED

GDAP2

26

Q9NXN4
FETIDLSQATVAESS

DGKK

256

Q5KSL6
ETSEFLEQQLTSDII

GPR61

421

Q9BZJ8
STEVDESLSVSFEQV

MAP1S

691

Q66K74
VASLQDSSLEEEQFT

GIGYF1

436

O75420
VDDFSFIDQTSVLDS

KIAA1671

1626

Q9BY89
EQLDTNDESDFISTL

LRRC37A2

1106

A6NM11
EQLDTNDESDFISTL

LRRC37A

1106

A6NMS7
QSVTEQSSLDDFLAT

LSG1

51

Q9H089
QLAEQSLASSEDETE

RPGRIP1L

1051

Q68CZ1
TSDEEIFISQDEIQS

GGNBP2

636

Q9H3C7
SDIQVTELSDADTVS

HERC2

2506

O95714
SENLAFIDESSDTQS

KCNK4

341

Q9NYG8
NSSNILSELDEEFDS

FSD1L

71

Q9BXM9
LAESSEEQEDALNIS

ANLN

591

Q9NQW6
FASTEEESSNESLLV

ATAD2B

1231

Q9ULI0
DLTFTVTLENLTADD

CD300H

91

A0A0K2S4Q6
EEDFSSNDLSSITEQ

FAM13B

216

Q9NYF5
EDFSLDSSLSQVQVE

KCNT1

56

Q5JUK3
FDLISDSEASQEETT

PCLO

176

Q9Y6V0
RSDNETLNIQFEEST

KIAA0232

721

Q92628
IQENLSFTLENSEED

PCDHGA9

386

Q9Y5G4
TTDEDSTRFQIINEA

GANC

51

Q8TET4
QSITDNENDETFVTL

CYB5RL

201

Q6IPT4
DNSELELTSVVENTF

MYNN

231

Q9NPC7
SDLSDLSDSEEQLQA

KDM3B

816

Q7LBC6
TLFKLASETEDNDNS

GGA3

261

Q9NZ52
TDQSTFDILQDLEFS

NR3C1

186

P04150
ASQADSTEQVDDTIL

GCN1

2656

Q92616
TELEDTLDSTAAQQE

MYH9

1146

P35579
RELQVQDSTLSESTF

NLRP4

641

Q96MN2
DNSAVTLSILDENDD

PCDH11X

601

Q9BZA7
EETSTDITNFNLEKD

PAXBP1

561

Q9Y5B6
EDQLKSENLEVSSSF

HELZ

1841

P42694
TELEDSFTEQVQSLA

IQSEC3

396

Q9UPP2
ESSFQITEETQIDTT

ITGB4

81

P16144
DQRDFTNSSSQEEID

PPP2R3A

496

Q06190
VFDFDNTIIDDNSDT

PHOSPHO2

6

Q8TCD6
ADDEELTNDSLTLSQ

PHF14

281

O94880
EITATQLTTSADLDE

CDC25C

81

P30307
VDRSFTDQSTLQEDE

PTPRU

806

Q92729
SSTVFLSIDVEDQND

DCHS2

1491

Q6V1P9
TFEEDQVDSTLIDSS

NBPF3

286

Q9H094
TDSSAELQSLEQQLE

EEA1

131

Q15075
ETQTDFLLADTSAQS

ATMIN

671

O43313
LVDSSELQEAVLTES

HTRA3

416

P83110
SDALQLENSQEIETS

ICE2

511

Q659A1
ISSNVLEESAVSDDV

DOCK7

1741

Q96N67
SSNVLEESVVSEDTL

DOCK8

1696

Q8NF50
DDITSVDDFLSVSEN

CTNNA2

501

P26232
FSDIENISEETSAEV

BRCA2

1241

P51587
FLDDNQIVTSSGDTT

GNB1

151

P62873
ALQTVDTELTADSVE

DPH7

6

Q9BTV6
ENEVSTSATDELLSQ

CHD2

1006

O14647
AQKESLSEEEATSFI

DAPK2

116

Q9UIK4
SATFEDLDAQVNSET

DCST1

191

Q5T197
IEDQSETEANVSLAS

FBN1

2741

P35555
SSSDQEQVDVESIDF

CHAMP1

651

Q96JM3
RSESDVSSVEQDSFI

CEP89

76

Q96ST8
LEALSVSEEQQTSDN

FRMPD4

876

Q14CM0
ENSLELDSSIFSQFD

CEP250

366

Q9BV73
TELLFDTIDSSEVNV

FASTKD1

216

Q53R41
SSDVLENVFSSLTDD

GOLPH3L

231

Q9H4A5
QESEQSDDELLTLSS

DNAJC6

451

O75061
SSIDEQVQTAADDSL

CEP350

1571

Q5VT06
SEEQSEASSEQLDQF

FAM169A

611

Q9Y6X4
EASSEQLDQFTQSAE

FAM169A

616

Q9Y6X4
QFVLQEEFSSDDSTT

MS4A14

181

Q96JA4
ELQTIQEDSAATSES

MBP

116

P02686
LQSQDFSLDSSAEEE

FAM102B

311

Q5T8I3
LDLTQTDISDSAFDS

FBXL5

361

Q9UKA1
VLSDEEASFESEQAN

ICA1L

291

Q8NDH6
EFSEESESLTTLQAA

SDK2

1486

Q58EX2
RQDEDSSFLSQNETE

SLC39A12

151

Q504Y0
TVEEQASTTERVFQD

CUL4B

831

Q13620
LDNIVSLTTAESESF

PPP1R3B

96

Q86XI6
SLSQEVQDSFSFLED

ARHGAP30

501

Q7Z6I6
TSSERNISELESFEE

RP1

1456

P56715
EESIDALVSSQLSTN

SYTL5

361

Q8TDW5
TEDQALVSSVEDILS

SPAG5

291

Q96R06
SVFSENTEDLQEQFT

MIA3

191

Q5JRA6
DNRESQDTSFTTLVE

GFPT1

161

Q06210
VNSILVVDSESSQDE

NBPF7P

256

P0C2Y1
TEEFNSDISLSDNTT

RIF1

1966

Q5UIP0
VEESLTDTQLVSFQS

SEC24A

791

O95486
KEEEIFSLFNSSDTN

SLC26A8

586

Q96RN1
LDQDSVSDQFSVEFE

MDM2

236

Q00987
DSSSDAEEDNLFLTQ

SETX

1486

Q7Z333
DDDVTVITNLSSVEA

TENM2

1741

Q9NT68
SSSEETLNNFQEAET

TSC22D1

171

Q15714
DELTVQISQETTADA

KDF1

346

Q8NAX2
DVINSEAITFTDDFS

MSRB3

111

Q8IXL7
ARLQTVDFEQSTEET

SERPINB11

131

Q96P15
NLFTTDEEEEQAALT

OSCP1

321

Q8WVF1
SDATNFTINLVTDEE

SLC10A5

81

Q5PT55
EEVQTSASDLLDSQD

PAG1

106

Q9NWQ8
NLDTSSSDFTILQEI

SAFB

191

Q15424
ISSNLISFTEVDDAE

CNNM4

86

Q6P4Q7
RLFDDSTVTTVDESQ

USP19

1186

O94966
TDSTETQEDQINLDL

ZNF804B

1086

A4D1E1
SDNEDLLQELSSIES

UNC13C

111

Q8NB66
SSSIENLESEAVFEA

SPEG

2321

Q15772
ANSTDLFDEIVTATT

SYBU

436

Q9NX95
DEIQVDASSFESTAN

KIF3B

696

O15066
NESDSATTQFTTEID

TNR

581

Q92752
AESDELTVENVASSV

XRN1

696

Q8IZH2
TSSRETNAFLEVNEE

SLC10A6

336

Q3KNW5
VEIDNETEQKSESFS

SUCO

771

Q9UBS9
TFNLNNFETSDTEEE

ZGRF1

531

Q86YA3
SSSELSVDSEVEFQL

ZCCHC7

21

Q8N3Z6
ASNQTEVEFSSIKDE

ZNF462

51

Q96JM2
DLTNVDTTTDNSVLE

TRPV3

391

Q8NET8
SQFSESDAALQEELS

ZNF18

21

P17022
ELLEGNSSQDSFEVT

SIGLEC10

481

Q96LC7
LSLQEAETEQSDTLD

ARHGAP21

716

Q5T5U3
DEQDFSSKDNLVSSI

ZMYM4

91

Q5VZL5
ITDQNELSLDDTTDQ

ZBBX

681

A8MT70
SVLSSDNQFNEESLE

LNPK

341

Q9C0E8
ETEQLLQEEQSECSS

LRP4

1861

O75096
SELTSADESENLNIL

N4BP2

1081

Q86UW6